What does aducanumab treatment of Alzheimer's disease mean for research on vascular cognitive disorders?

ABSTRACT: •Controversial registration of aducanumab for Alzheimer's Disease•Aducanumab is the subject of post-licensing observational studies aiming to follow the effects of the drug•Given the high prevalence of cerebrovascular pathology it is important that these studies do not ignore vascular cognitive disorders•The studies may give detailed phenotyping data that may lead to knowledge of targets for treatments of patients with vascular cognitive disorders.

SUBMITTER: Wallin A 

PROVIDER: S-EPMC9616233 | biostudies-literature | 2022

REPOSITORIES: biostudies-literature